Abstract
Oxidative stress is the main pathophysiological mechanism involved in the development of stroke. Severe DNA damage induced by oxidative stress or apoptotic stimuli activates poly (ADP-ribose) polymerase (PARP), causing a rapid depletion of nuclear NAD pools, cellular energy, and thiols. The biochemical activity of nicotinamide in the body is based on its conversion into NAD. Nicotinamide and its structural analogues possess a weak inhibitory effect on PARP. Nicotinamide exerts its neuroprotective effects by increasing NAD synthesis and ATP production indirectly and inhibiting PARP directly. By inhibiting PARP, membrane phosphatidylserine exposure and DNA fragmentation, nicotinamide can prevent brain necrosis and apoptosis effectively. Administration of nicotinamide at an early stage of stroke provides a new means to rescue the still viable but injured nerve cells within the ischemic and limit areas.
Keywords: Nicotinamide, DNA fragmentation, apoptosis, neuroprotective
Letters in Drug Design & Discovery
Title: Structure Activity Relationships for Nicotinamide in the Treatment of Stroke
Volume: 1 Issue: 1
Author(s): Jun Yang and James D. Adams Jr.
Affiliation:
Keywords: Nicotinamide, DNA fragmentation, apoptosis, neuroprotective
Abstract: Oxidative stress is the main pathophysiological mechanism involved in the development of stroke. Severe DNA damage induced by oxidative stress or apoptotic stimuli activates poly (ADP-ribose) polymerase (PARP), causing a rapid depletion of nuclear NAD pools, cellular energy, and thiols. The biochemical activity of nicotinamide in the body is based on its conversion into NAD. Nicotinamide and its structural analogues possess a weak inhibitory effect on PARP. Nicotinamide exerts its neuroprotective effects by increasing NAD synthesis and ATP production indirectly and inhibiting PARP directly. By inhibiting PARP, membrane phosphatidylserine exposure and DNA fragmentation, nicotinamide can prevent brain necrosis and apoptosis effectively. Administration of nicotinamide at an early stage of stroke provides a new means to rescue the still viable but injured nerve cells within the ischemic and limit areas.
Export Options
About this article
Cite this article as:
Yang Jun and Adams Jr. D. James, Structure Activity Relationships for Nicotinamide in the Treatment of Stroke, Letters in Drug Design & Discovery 2004; 1 (1) . https://dx.doi.org/10.2174/1570180043485716
DOI https://dx.doi.org/10.2174/1570180043485716 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical Design Detection of the Artery of Adamkiewicz Before Open Surgery and Endovascular Aortic Repair: A Review
Current Medical Imaging The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice
CNS & Neurological Disorders - Drug Targets Q Fever Endocarditis
Infectious Disorders - Drug Targets Immunopathology of Brucella Infection
Recent Patents on Anti-Infective Drug Discovery HDL Stimulates apoM Secretion
Protein & Peptide Letters Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Basic and Clinical Aspects of Gene Therapy for Retinopathy Induced by Diabetes
Current Gene Therapy Drug Therapy for Abdominal Aortic Aneurysms Utilizing Omega-3 Unsaturated Fatty Acids and Their Derivatives
Current Drug Targets Stairway to Heaven or Hell? Perspectives and Limitations of Chagas Disease Chemotherapy
Current Topics in Medicinal Chemistry Hemolytic Uremic Syndrome in Children
Current Pediatric Reviews Heart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem
Current Cardiology Reviews Cardiovascular and Hematological Medicine in 2019 – Advances and Insights
Cardiovascular & Hematological Agents in Medicinal Chemistry Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Current Vascular Pharmacology Biological, Geometric and Biomechanical Factors Influencing Abdominal Aortic Aneurysm Rupture Risk: A Comprehensive Review
Recent Patents on Medical Imaging MicroRNAs as Early Biomarkers in Obesity and Related Metabolic and Cardiovascular Diseases
Current Pharmaceutical Design Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders Current Evidence for Antithrombotic Therapy after Peripheral Vascular Interventions
Current Vascular Pharmacology The Effect of TNFα-Inhibitors on Cardiovascular Events in Patients with Rheumatoid Arthritis: An Updated Systematic Review of the Literature
Current Rheumatology Reviews